Scribd
Upload
53 views

Vinay M

Cipla is an Indian pharmaceutical company founded in 1935 and headquartered in Mumbai, India. It has over 2000 products across 65 therapeutic categories and is one of the largest pharmaceutical companies worldwide. The company is led by Chairman Y.K. Hamied and has a vision to build a healthy India through using the latest pharmaceutical technology and over seven decades of experience.

Uploaded by

Muralis Muralis
Copyright
© Attribution Non-Commercial (BY-NC)
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
53 views

Vinay M

Cipla is an Indian pharmaceutical company founded in 1935 and headquartered in Mumbai, India. It has over 2000 products across 65 therapeutic categories and is one of the largest pharmaceutical companies worldwide. The company is led by Chairman Y.K. Hamied and has a vision to build a healthy India through using the latest pharmaceutical technology and over seven decades of experience.

Uploaded by

Muralis Muralis
Copyright
© Attribution Non-Commercial (BY-NC)
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
You are on page 1/ 16

Type >>> Industry>>> Founded>>>

Public. Pharmaceutical. 1935.

Headquarters>>>
Key people>>> Products>>>

Mumbai, Maharashtra.
Y. K.Hamied, Chairman. Pharmaceuticals and diagnostics.

Ciplas journey began in 1935. Founder, Dr. K. A. Hamied, set up an enterprise. Over the past 77 years, it have emerged as one of the worlds largest pharmaceutical company. With over 2000 products in 65 therapeutic categories.

VISION

Cipla started with a vision to build a healthy India.

MISSION

Company use the latest in pharmaceutical technology to tunnel over seven decades of experience into one capsule that cures,one drop that defends and one puff that protect.

Managing Director Whole-time Director Chairman


Dr. Yusuf K Hamied Mr. Mr. S. M.K. Radhakrishnan Hamied

Founder Dr. K.A.Hamied


Chairman Dr. Yusuf K Hamied

Managing Director Mr. M.K. Hamied Whole-time Director Mr. S. Radhakrishnan

Non-Executive Directors Dr. H.R.Manchanda Mr.Ramesh Shroff Mr. V.C.Kotwal Mr. M.R.Raghavan Mr. Pankaj Patel Dr. Ranjan Pai

Recruitment process.. From top university. Selection process.. Written examination, Interview or Group Discussion and strictly in the order of Merit.

Face Value Operating Profit Margin(%) Gross Profit Margin(%) Net Profit Margin(%) Current Ratio Interest Coverage ratio Inventory Turnover Ratio

2.00 23.62

19.18
15.98 2.61 38.76 3.85

.Strengths. . Cipla has developed good positive image by providing support to cancer patients by issuing drugs at low cost. A foremost player in anti-infective and anti-asthmatic formulations. Has a strong employee force of over 16,000.

.Weakness. Strong competition from international and domestic giants means limited market share. .Opportunity. It can venture into Alzheimers disease medication. Increased investment in the budding markets, to push expansion in the global economy.

.Threats. 1.The Indian Rupee depreciated as compared to the US Dollar 2. Fluctuations in currency exchange rates have a impact on the Companys operations and financial results.

Segment :AIDS, respiratory disease, cancer cardiovascular disease, arthritis Target Group :Customers of various flavors and fragrances, prescription products, pesticides, agrochemicals, doctors Positioning :They use latest technology to concentrate all their knowledge of over seven decades in developing life saving drugs.

Products manufactured by Cipla: Omni Gel Clocip-B Ciplox-Cream Clocip Dusting Powder Reactin Gel Nicip Gel Cipladine Powder Mobix Cream Power Gel Burnheal Micogel-F Mobicam Gel Soft Heal (Foot Care Cream)

1. Sun Pharmaceuticals 2. Dr. Reddys laboratories 3. Lupin 4. Ranbaxy labs

PATIENT EDUCATION.

DOCTOR SERVICES.
PALLIATIVE CARE.

Honoured with the CNN-IBN Indian of the Year Award 2012 (Business Category) Award in the export of Pharmaceuticals during year 2011-12 Conferred the highest award Platinum The Conscious Capitalist at Forbes India Leadership Awards 2012 For Best Company in an Emerging Market in 2006.

You might also like